Scleroderma in childhood.
D000293:Adolescent; D002493:Central Nervous System Diseases / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D008297:Male; D010396:Penicillamine / Q000627:therapeutic use; D011379:Prognosis; D012594:Scleroderma, Localized / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D012595:Scleroderma, Systemic / Q000401:mortality / Q000473:pathology
D007166:Immunosuppressive Agents; D010396:Penicillamine